Evommune Locks Down Palo Alto Space from Hudson Pacific as Clinical Trials Advance

The biotech startup is betting on growth with new office space in Palo Alto and New York as it prepares for three Phase 2 data readouts in 2026 Evommune Inc., the clinical-stage biotechnology company focused on chronic inflammatory diseases, is expanding its physical presence with significant new office leases, signaling confidence in its pipeline despite […]